DUBLIN–(BUSINESS WIRE)–The “Lynparza
– API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s
offering.
Lynparza – API Insight, 2019 provides product and API
manufacturers’ details across the globe along with the location. The
report gives the clear idea on the country wise DMF filed by worldwide
companies related to Lynparza. The report also highlights the patent
details of Lynparza.
Scope of the Report
-
A comprehensive product overview including product description,
regulatory milestones, safety, pharmacological properties, clinical
trials, and product development activities have been elaborated in
this report -
Patent information around Lynparza in United States (US) and Europe
(EU) has been highlighted -
API manufacturers for Lynparza in United States, Europe, China and
India -
The report contains historical and forecasted sales for Lynparza till
2021 -
Enlists the market competition and emerging therapies in the space
where Lynparza operates
Reasons to Buy
-
Evaluate the marketing status of Lynparza to exploit opportunities for
generic Lynparza development opportunities -
Design effective counter-strategies to gain competitive advantage by
identifying the key patent expiry details with respect to Lynparza -
API intelligence over Lynparza and gaining primary intelligence over
Active Ingredient manufacturers by country -
Make more informed business decisions from insightful and in-depth
analysis of Lynparza’s performance
Key Topics Covered
1. Lynparza Overview
2. Lynparza Global Sales Assessment
- Lynparza Historical Global Sales
- Lynparza Forecasted Global Sales
3. Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
4. Product Details by country
5. Patent Information
6. Global API Manufacturers Assessment
- Active Pharmaceutical Ingredient (API) Manufacturers by Country
- Active Pharmaceutical Ingredient (API) Manufacturers by Region
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/c7b2z3
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Ovarian
Cancer Drugs